CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1755-1762

  Woods, Keith M ^a   Pope, Michael R ^a   Hoffman, Sara M ^a   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3 RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; COMPLEMENT ACTIVATION; FOLLICULAR B CELL; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; INTESTINE INJURY; INTESTINE ISCHEMIA; MARGINAL ZONE B CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; COMPLEMENT C3; HOMEODOMAIN PROTEINS; IMMUNOPHENOTYPING; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT 3D; REPERFUSION INJURY; SPLEEN;

EID: 79251544265     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002059     Document Type: Article

References (55)

1. Arumugam, T. V., T. Magnus, T. M. Woodruff, L. M. Proctor, I. A. Shiels, and S. M. Taylor. 2006. Complement mediators in ischemia-reperfusion injury. Clin. Chim. Acta 374: 33-45.
2. Holers, V. M., and L. Kulik. 2007. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol. Immunol. 44: 64-72.
3. Zhang, M., and M. C. Carroll. 2007. Natural antibody mediated innate autoimmune response. Mol. Immunol. 44: 103-110.
4. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192: 271-280.
5. Baumgarth, N., J. W. Tung, and L. A. Herzenberg. 2005. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26: 347-362.
6. Boes, M. 2000. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 37: 1141-1149.
7. Durand, C. A., K. Hartvigsen, L. Fogelstrand, S. Kim, S. Iritani, B. Vanhaesebroeck, J. L. Witztum, K. D. Puri, and M. R. Gold. 2009. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J. Immunol. 183: 5673-5684.
8. Lutz, H. U. 2007. Homeostatic roles of naturally occurring antibodies: an overview. J. Autoimmun. 29: 287-294. (Pubitemid 47633143)
9. Lutz, H. U., C. J. Binder, and S. Kaveri. 2009. Naturally occurring autoantibodies in homeostasis and disease. Trends Immunol. 30: 43-51.
10. Boes, M., C. Esau, M. B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160: 4776-4787.
11. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
12. Weiser, M. R., J. P. Williams, F. D. Moore, Jr., L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183: 2343-2348.
13. Zhang, M., E. M. Alicot, I. Chiu, J. Li, N. Verna, T. Vorup-Jensen, B. Kessler, M. Shimaoka, R. Chan, D. Friend, et al. 2006. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203: 141-152.
14. Fleming, S. D., R. P. Egan, C. Chai, G. Girardi, V. M. Holers, J. Salmon, M. Monestier, and G. C. Tsokos. 2004. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J. Immunol. 173: 7055-7061.
15. -/-) mice. Autoimmunity 40: 208-216.
16. Kulik, L., S. D. Fleming, C. Moratz, J. W. Reuter, A. Novikov, K. Chen, K. A. Andrews, A. Markaryan, R. J. Quigg, G. J. Silverman, et al. 2009. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J. Immunol. 182: 5363-5373.
17. Hart, M. L., K. A. Ceonzo, L. A. Shaffer, K. Takahashi, R. P. Rother, W. R. Reenstra, J. A. Buras, and G. L. Stahl. 2005. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J. Immunol. 174: 6373-6380.
18. Walsh, M. C., T. Bourcier, K. Takahashi, L. Shi, M. N. Busche, R. P. Rother, S. D. Solomon, R. A. Ezekowitz, and G. L. Stahl. 2005. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J. Immunol. 175: 541-546.
19. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348-350.
20. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
21. Tedder, T. F., L. J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15: 437-442. (Pubitemid 24272189)
22. Iida, K., L. Nadler, and V. Nussenzweig. 1983. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158: 1021-1033.
23. Prota, A. E., D. R. Sage, T. Stehle, and J. D. Fingeroth. 2002. The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc. Natl. Acad. Sci. USA 99: 10641-10646.
24. Asokan, R., J. Hua, K. A. Young, H. J. Gould, J. P. Hannan, D. M. Kraus, G. Szakonyi, G. J. Grundy, X. S. Chen, M. K. Crow, and V. M. Holers. 2006. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J. Immunol. 177: 383-394.
25. Fingeroth, J. D., J. J. Weis, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81: 4510-4514.
26. Frade, R., B. L. Myones, M. Barel, L. Krikorian, C. Charriaut, and G. D. Ross. 1985. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Eur. J. Immunol. 15: 1192-1197.
27. Aubry, J. P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried, and J. Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152: 5806-5813.
28. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172.
29. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169: 2126-2133.
30. Williams, J. P., T. T. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, Jr., M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86: 938-942.
31. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
32. Won, W.-J., and J. F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168: 5605-5611.
33. Hardy, R. R. 2006. B-1 B cells: development, selection, natural autoantibody and leukemia. Curr. Opin. Immunol. 18: 547-555.
34. Markiewski, M. M., R. A. DeAngelis, C. W. Strey, P. G. Foukas, C. Gerard, N. Gerard, R. A. Wetsel, and J. D. Lambris. 2009. The regulation of liver cell survival by complement. J. Immunol. 182: 5412-5418.
35. Chiu, C.-J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101: 478-483.
36. Reid, R. R., S. Woodcock, A. P. Prodeus, J. Austen, L. Kobzik, H. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2000. The role of complement receptors CD21/CD35 in positive selection of B-1 cells. Curr. Top. Microbiol. Immunol. 252: 57-65.
37. Martin, F., and J. F. Kearney. 2001. B1 cells: similarities and differences with other B cell subsets. Curr. Opin. Immunol. 13: 195-201.
38. Hill, J., T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore, Jr. 1992. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149: 1723-1728.
39. Fruchterman, T. M., D. A. Spain, M. A. Wilson, P. D. Harris, and R. N. Garrison. 1998. Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124: 782-791, discussion 791-792.
40. Fleming, S. D. 2006. Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 39: 379-386. (Pubitemid 44269615)
41. Arumugam, T. V., I. A. Shiels, T. M. Woodruff, D. N. Granger, and S. M. Taylor. 2004. The role of the complement system in ischemia-reperfusion injury. Shock 21: 401-409.
42. Haas, K. M., J. C. Poe, and T. F. Tedder. 2009. CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J. Immunol. 183: 3661-3671.
43. Wang, J. H., J. Li, Q. Wu, P. Yang, R. D. Pawar, S. Xie, L. Timares, C. Raman, D. D. Chaplin, L. Lu, et al. 2010. Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity. J. Immunol. 184: 442-451.
44. Haas, K. M., F. R. Toapanta, J. A. Oliver, J. C. Poe, J. H. Weis, D. R. Karp, J. F. Bower, T. M. Ross, and T. F. Tedder. 2004. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 172: 5833-5837.
45. Prodeus, A. P., S. Goerg, L. M. Shen, O. O. Pozdnyakova, L. Chu, E. M. Alicot, C. C. Goodnow, and M. C. Carroll. 1998. A critical role for complement in maintenance of self-tolerance. Immunity 9: 721-731.
46. Jacobson, A. C., K. M. Roundy, J. J. Weis, and J. H. Weis. 2009. Regulation of murine splenic B cell CR3 expression by complement component 3. J. Immunol. 183: 3963-3970.
47. Sohn, J. H., P. S. Bora, H. J. Suk, H. Molina, H. J. Kaplan, and N. S. Bora. 2003. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat. Med. 9: 206-212.
48. Pappworth, I. Y., L. Kulik, C. Haluszczak, J. W. Reuter, V. M. Holers, and K. J. Marchbank. 2009. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). Mol. Immunol. 46: 1042-1049.
49. Reid, R. R., S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen, Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2002. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169: 5433-5440.
50. Molina, H. 2002. The murine complement regulator Crry: new insights into the immunobiology of complement regulation. Cell. Mol. Life Sci. 59: 220-229.
51. Fang, Y., C. Xu, Y. X. Fu, V. M. Holers, and H. Molina. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160: 5273-5279.
52. Molnár, E., J. Prechl, and A. Erdei. 2008. Novel roles for murine complement receptors type 1 and 2 II. Expression and function of CR1/2 on murine mesenteric lymph node T cells. Immunol. Lett. 116: 163-167.
53. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
54. Rossbacher, J., A. M. Haberman, S. Neschen, A. Khalil, and M. J. Shlomchik. 2006. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35. Eur. J. Immunol. 36: 2384-2393.
55. Chen, J., J. C. Crispín, T. F. Tedder, J. Dalle Lucca, and G. C. Tsokos. 2009. B cells contribute to ischemia/reperfusion-mediated tissue injury. J. Autoimmun. 32: 195-200.